TRHC in the Media - Tabula Rasa HealthCare

Tabula Rasa HealthCare in the Media

In The News | Jun 23, 2022

Recently, Tabula Rasa HealthCare leadership and staff discussed medication management, the future of PACE, the ever-evolving demands on pharmacists, and more in the media.

4 supplements that can become lethal when combined with certain prescription medications, according to a pharmacologist

Tabula Rasa HealthCare’s Chief Pharmacotherapy Officer Robert Alesiani recently spoke with Insider about the everyday vitamins that could turn lethal when combined with certain prescription medications.

How Pharmacists Can Use Advanced Medication Decision Support to Improve Health, Curtail Costs

An article in Pharmacy Times written by Mindy Smith, Tabula Rasa HealthCare’s Senior Vice President, Government & Professional Affairs, outlines ways to support pharmacists as their role in the health of our communities continues to grow.

The Need for Patient-Specific Medication Optimization Systems

In a recent article for Drug Store News, Michael S. Awadalla, PharmD, BCGP, Executive Vice President Office of Applied Pharmacotherapy at Tabula Rasa HealthCare said, “sophisticated medication risk management is critical to minimize the chance that a patient’s drug regimen could potentially cause medication-related harm.”

Pharmacists Play Role in Pharmacogenomics Clinical Services

Veronique Michaud, Jacques Turgeon, and their co-authors recently discussed why pharmacists should be recognized as the experts and owners when it comes to ordering and interpreting pharmacogenomic test results in an article for Pharmacy Times.

Dr. Alexis Garcia Discusses Medication Therapy Management Programs

In a recent video discussion with the American Journal of Managed Care, Alexis Garcia, PharmD, senior director of business development at Tabula Rasa HeathCare, explained the importance of up-to-date data when implementing medication therapy management programs.

Why we need a modern act to prevent harm from medications

Adverse drug events are a leading cause of death and cost billions of dollars each year. Recently, Tabula Rasa HealthCare’s Chief Scientific Officer, Jacques Turgeon, and his co-authors shed light on uncoordinated prescription regimens and adverse drug events in The Hill.

The Future of PACE Programs Has Great Potential

In HomeCare Magazine, Tabula Rasa HealthCare’s Co-Founder and President, Orsula V. Knowlton, PharmD, MBA, discusses why there is such great potential in the future for PACE.

Connect with us!

Follow TRHC on Twitter, LinkedIn, or Facebook to stay up-to-date on all things Tabula Rasa HealthCare!

Share this:
Fill 1 Copy 2closeFill 5 Copy 4green-arrowhamburgerFill 7 Copy 4Fill 1 Copy 4pauseplaysearch-iconFill 3 Copy 4